Gene · 4082
Papers2,556
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 2,556
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Thousands of human non-AUG extended proteoforms lack evidence of evolutionary selection among mammals. | Nat Commun | 2022 | 36564405 | PubTator, text mining | PubMed |
| Immune cell-derived extracellular vesicular microRNAs induce pancreatic beta cell apoptosis. | Heliyon | 2022 | 36561684 | PubTator, text mining | PubMed |
| Proteomics and Phospho-Proteomics Profiling of the Co-Formulation of Type I and II Interferons, HeberFERON, in the Glioblastoma-Derived Cell Line U-87 MG. | Cells | 2022 | 36552831 | PubTator, text mining | PubMed |
| tRNA-like Transcripts from the NEAT1-MALAT1 Genomic Region Critically Influence Human Innate Immunity and Macrophage Functions. | Cells | 2022 | 36552736 | PubTator, text mining | PubMed |
| Increased MARCKS Activity in BRAF Inhibitor-Resistant Melanoma Cells Is Essential for Their Enhanced Metastatic Behavior Independent of Elevated WNT5A and IL-6 Signaling. | Cancers (Basel) | 2022 | 36551563 | PubTator, text mining | PubMed |
| Global Characteristics and Dynamics of Single Immune Cells After Myocardial Infarction. | J Am Heart Assoc | 2022 | 36515244 | PubTator, text mining | PubMed |
| Single-cell profiling of healthy human kidney reveals features of sex-based transcriptional programs and tissue-specific immunity. | Nat Commun | 2022 | 36496458 | PubTator, text mining | PubMed |
| Systems biology reveals anatabine to be an NRF2 activator. | Front Pharmacol | 2022 | 36467029 | PubTator, text mining | PubMed |
| A 69 kb Deletion in chr19q13.42 including PRPF31 Gene in a Chinese Family Affected with Autosomal Dominant Retinitis Pigmentosa. | J Clin Med | 2022 | 36431159 | PubTator, text mining | PubMed |
| Old and New Facts and Speculations on the Role of the B Cell Receptor in the Origin of Chronic Lymphocytic Leukemia. | Int J Mol Sci | 2022 | 36430731 | PubTator, text mining | PubMed |
| Harnessing Normal and Engineered Mesenchymal Stem Cells Derived Exosomes for Cancer Therapy: Opportunity and Challenges. | Int J Mol Sci | 2022 | 36430452 | PubTator, text mining | PubMed |
| C Type Natriuretic Peptide Receptor Activation Inhibits Sodium Channel Activity in Human Aortic Endothelial Cells by Activating the Diacylglycerol-Protein Kinase C Pathway. | Int J Mol Sci | 2022 | 36430437 | PubTator, text mining | PubMed |
| Phosphatidylinositol 4,5-Bisphosphate Mediates the Co-Distribution of Influenza A Hemagglutinin and Matrix Protein M1 at the Plasma Membrane. | Viruses | 2022 | 36423118 | PubTator, text mining | PubMed |
| A pyridinesulfonamide derivative FD268 suppresses cell proliferation and induces apoptosis via inhibiting PI3K pathway in acute myeloid leukemia. | PLoS One | 2022 | 36413544 | PubTator, text mining | PubMed |
| A genome-wide association study identifying single nucleotide polymorphisms in the PPFIBP2 gene was predictive for interstitial lung disease in rheumatoid arthritis patients. | Rheumatol Adv Pract | 2022 | 36382269 | PubTator, text mining | PubMed |
| Macrophages in health and disease. | Cell | 2022 | 36368305 | PubTator, text mining | PubMed |
| Cross-Talk and Subset Control of Microglia and Associated Myeloid Cells in Neurological Disorders. | Cells | 2022 | 36359758 | PubTator, text mining | PubMed |
| Current Perspectives on Adult Mesenchymal Stromal Cell-Derived Extracellular Vesicles: Biological Features and Clinical Indications. | Biomedicines | 2022 | 36359342 | PubTator, text mining | PubMed |
| The memory B cell response to influenza vaccination is impaired in older persons. | Cell Rep | 2022 | 36351385 | PubTator, text mining | PubMed |
| Natural killer cells in clinical development as non-engineered, engineered, and combination therapies. | J Hematol Oncol | 2022 | 36348457 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4082/papers?page=16